Supplementation with a single and double strain probiotic on the innate immune system for respiratory illness

e-SPEN Journal

Volumn 9, Issue 5, 2014, Pages e178-e184

  West, Nicholas P ^a   Horn, Peggy L ^b   Barrett, Susan ^a   Warren, Hilary S ^c   Lehtinen, Markus J ^f   Koerbin, Gus ^d   Brun, Mary ^d   Pyne, David B ^a,b,e   Lahtinen, Sampo J ^f   Fricker, Peter A ^b   Cripps, Allan W ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^c CANBERRA HOSPITAL   (Australia)

^d ACT Pathology   (Australia)

^e JAMES COOK UNIVERSITY   (Australia)

^f Danisco Finland Oy   (Finland)

Author keywords

B. animalis subsp. lactis Bi 07; Bifidobacterium animalis subsp. lactis Bl 04; Healthy adults; Innate immune; Lactobacillus acidophilus NCFM; Probiotics

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1 DELTA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NEUROTROPHIN; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BEVERAGE; BIFIDOBACTERIUM ANIMALIS; COLONY FORMING UNIT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INNATE IMMUNITY; LACTOBACILLUS ACIDOPHILUS; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE;

EID: 84927694508     PISSN: None     EISSN: 22128263     Source Type: Journal    
DOI: 10.1016/j.clnme.2014.06.003     Document Type: Article

References (31)

1. Grenham S., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbe communication in health and disease. Front Physiology 2011, 2:94. 10.3389/fphys.2011.00094.
2. Hao Q., Lu Z., Dong B.R., Huang C.Q., Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2011, 9:CD006895. 10.1002/14651858.CD006895.pub2.
3. West N.P., Horn P.L., Pyne D.B., Gebski V.J., Lahtinen S.J., Fricker P.A., et al. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals. Clin Nutr 2013.
4. Gleeson M., Williams C. Intense exercise training and immune function. Nestle Nutr Inst Workshop Ser 2013, 76:39-50. 10.1159/000350254.
5. Rask C., Adlerberth I., Berggren A., Ahren I.L., Wold A.E. Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli. Clin Exp Immunol 2013, 172(2):321-332. 10.1111/cei.12055.
6. Spiegel D.A. Grand challenge commentary: synthetic immunology to engineer human immunity. Nat Chem Biol 2010, 6(12):871-872.
7. Cox A.J., Pyne D.B., Saunders P.U., Fricker P.A. Oral administration of the probiotic lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 2010, 44(4):222-226. doi: bjsm.2007.044628 [pii]10.1136/bjsm.2007.044628.
8. Gill H.S., Rutherfurd K.J., Cross M.L. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. JClin Immunol 2001, 21(4):264-271.
9. Jirillo E., Jirillo F., Magrone T. Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune system. Int J Vitam Nutr Res Int Z fur Vitam- und Ernahr J Int De Vitaminol Et De Nutr 2012, 82(3):200-208. 10.1024/0300-9831/a000112.
10. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. JImmunol Methods 2004, 294(1-2):15-22.
11. Gleeson M., Bishop N.C., Oliveira M., McCauley T., Tauler P., Lawrence C. Effects of a Lactobacillus salivarius probiotic intervention on infection, cold symptom duration and severity, and mucosal immunity in endurance athletes. Int J Sport Nutr Exerc Metab 2012, 22(4):235-242. doi: 2012-0014 [pii].
12. Meyer A.L., Micksche M., Herbacek I., Elmadfa I. Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women. Ann Nutr Metab 2006, 50(3):282-289.
13. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009, 70(6):505-515.
14. Warren H.S., Wu F., Horn P.L., Pyne D.B., West N.P., Cripps A.W. Peripheral blood natural killer (NK) cell function in healthy adults assessed using the target-induced NK loss (TINKL) assay. JImmunol Methods 2013.
15. Olivares M., Paz Diaz-Ropero M., Gomez N., Sierra S., Lara-Villoslada F., Martin R., et al. Dietary deprivation of fermented foods causes a fall in innate immune response. Lactic acid bacteria can counteract the immunological effect of this deprivation. JDairy Res 2006, 73(4):492-498.
16. Klein A., Friedrich U., Vogelsang H., Jahreis G. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults. Eur J Clin Nutr 2008, 62(5):584-593.
17. Seifert S., Bub A., Franz C.M., Watzl B. Probiotic Lactobacillus casei Shirota supplementation does not modulate immunity in healthy men with reduced natural killer cell activity. JNutr 2011, 141(5):978-984.
18. Christensen H.R., Larsen C.N., Kaestel P., Rosholm L.B., Sternberg C., Michaelsen K.F., et al. Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults. FEMS Immunol Med Microbiol 2006, 47(3):380-390.
19. EFSA on Dietetic Products, Nutrition and Allergies (NDA) Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J 2011, 9(4):12. EFSA (Ed.).
20. Youn B.S., Zhang S.M., Lee E.K., Park D.H., Broxmeyer H.E., Murphy P.M., et al. Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. JImmunol 1997, 159(11):5201-5205.
21. Joubert P., Lajoie-Kadoch S., Wellemans V., Letuve S., Tulic M.K., Halayko A.J., et al. Expression and regulation of CCL15 by human airway smooth muscle cells. Clin Exp Allergy 2012, 42(1):85-94. 10.1111/j.1365-2222.2011.03894.x.
22. Kar S., Subbaram S., Carrico P.M., Melendez J.A. Redox-control of matrix metalloproteinase-1: a critical link between free radicals, matrix remodeling and degenerative disease. Respir Physiol Neurobiol 2010, 174(3):299-306.
23. Ravi A., Garg P., Sitaraman S.V. Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?. Inflamm Bowel Dis 2007, 13(1):97-107. 10.1002/ibd.20011.
24. Stallmach A., Chan C.C., Ecker K.W., Feifel G., Herbst H., Schuppan D., et al. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 2000, 47(3):415-422.
25. von Lampe B., Barthel B., Coupland S.E., Riecken E.O., Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000, 47(1):63-73.
26. Wang Y.D., Tan X.Y., Zhang K. Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis. Mediat Inflamm 2009, 2009:275072. 10.1155/2009/275072.
27. Walsh N.P., Gleeson M., Pyne D.B., Nieman D.C., Dhabhar F.S., Shephard R.J., et al. Position statement. Part two: maintaining immune health. Exerc Immunol Rev 2011, 17:64-103.
28. Maneerat S., Lehtinen M.J., Childs C.E., Forssten S.D., Alhoniemi E., Tiphaine M., et al. Consumption of bifidobacterium lactis Bi-07 by healthy elderly adults enhances phagocytic activity of monocytes and granulocytes. JNutr Sci 2013, 2:e44. 10.1017/jns.2013.31.
29. Mandrekar S.J., Sargent D.J. Predictive biomarker validation in practice: lessons from real trials. Clin Trials 2010, 7(5):567-573.
30. Gleeson M., Pyne D.B., Callister R. The missing links in exercise effects on mucosal immunity. Exerc Immunol Rev 2004, 10:107-128.
31. Smulders Y.M. Atwo-step manuscript submission process can reduce publication bias. JClin Epidemiol 2013, 66(9):946-947.